These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 9918992)

  • 21. Pseudomonas aeruginosa population biology in chronic obstructive pulmonary disease.
    Rakhimova E; Wiehlmann L; Brauer AL; Sethi S; Murphy TF; Tümmler B
    J Infect Dis; 2009 Dec; 200(12):1928-35. PubMed ID: 19919307
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Genotyping of Pseudomonas aeruginosa in cystic fibrosis suggests need for segregation.
    Edenborough FP; Stone HR; Kelly SJ; Zadik P; Doherty CJ; Govan JR
    J Cyst Fibros; 2004 Mar; 3(1):37-44. PubMed ID: 15463885
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromosomal mechanisms of aminoglycoside resistance in Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Islam S; Oh H; Jalal S; Karpati F; Ciofu O; Høiby N; Wretlind B
    Clin Microbiol Infect; 2009 Jan; 15(1):60-6. PubMed ID: 19154484
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Differences in prevalence and treatment of Pseudomonas aeruginosa in cystic fibrosis centres in Denmark, Norway and Sweden.
    Knudsen PK; Olesen HV; Høiby N; Johannesson M; Karpati F; Laerum BN; Meyer P; Pressler T; Lindblad A;
    J Cyst Fibros; 2009 Mar; 8(2):135-42. PubMed ID: 19157995
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Decreased virulence of cystic fibrosis Pseudomonas aeruginosa in Dictyostelium discoideum.
    Bradbury RS; Reid DW; Inglis TJ; Champion AC
    Microbiol Immunol; 2011 Apr; 55(4):224-30. PubMed ID: 21272061
    [TBL] [Abstract][Full Text] [Related]  

  • 26. High genotypic diversity of Pseudomonas aeruginosa strains isolated from patients with cystic fibrosis in the Czech Republic.
    Vosahlikova S; Drevinek P; Cinek O; Pohunek P; Maixnerova M; Urbaskova P; van den Reijden TJ; Dijkshoorn L; Nemec A
    Res Microbiol; 2007 May; 158(4):324-9. PubMed ID: 17448645
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Pseudomonas aeruginosa population diversity and turnover in cystic fibrosis chronic infections.
    Mowat E; Paterson S; Fothergill JL; Wright EA; Ledson MJ; Walshaw MJ; Brockhurst MA; Winstanley C
    Am J Respir Crit Care Med; 2011 Jun; 183(12):1674-9. PubMed ID: 21297072
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Stage-specific adaptation of hypermutable Pseudomonas aeruginosa isolates during chronic pulmonary infection in patients with cystic fibrosis.
    Hogardt M; Hoboth C; Schmoldt S; Henke C; Bader L; Heesemann J
    J Infect Dis; 2007 Jan; 195(1):70-80. PubMed ID: 17152010
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Genome diversity of Pseudomonas aeruginosa isolates from cystic fibrosis patients and the hospital environment.
    Finnan S; Morrissey JP; O'Gara F; Boyd EF
    J Clin Microbiol; 2004 Dec; 42(12):5783-92. PubMed ID: 15583313
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Fcgamma receptor IIA genotype and susceptibility to P. aeruginosa infection in patients with cystic fibrosis.
    De Rose V; Arduino C; Cappello N; Piana R; Salmin P; Bardessono M; Goia M; Padoan R; Bignamini E; Costantini D; Pizzamiglio G; Bennato V; Colombo C; Giunta A; Piazza A
    Eur J Hum Genet; 2005 Jan; 13(1):96-101. PubMed ID: 15367919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genotype and antibiotic susceptibility patterns of Pseudomonas aeruginosa and Stenotrophomonas maltophilia isolated from cystic fibrosis patients.
    Nazik H; Ongen B; Erturan Z; Salcioğlu M
    Jpn J Infect Dis; 2007 May; 60(2-3):82-6. PubMed ID: 17515637
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of antimicrobial sensitivity patterns as markers of Pseudomonas aeruginosa cross-infection at a cystic fibrosis clinic.
    Williams T
    Br J Biomed Sci; 1997 Sep; 54(3):181-5. PubMed ID: 9499595
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Comparison of ribotyping and genome fingerprinting of Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Bennekov T; Colding H; Ojeniyi B; Bentzon MW; Høiby N
    J Clin Microbiol; 1996 Jan; 34(1):202-4. PubMed ID: 8748305
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Shared Pseudomonas aeruginosa genotypes are common in Australian cystic fibrosis centres.
    Kidd TJ; Ramsay KA; Hu H; Marks GB; Wainwright CE; Bye PT; Elkins MR; Robinson PJ; Rose BR; Wilson JW; Grimwood K; Bell SC;
    Eur Respir J; 2013 May; 41(5):1091-100. PubMed ID: 22878877
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Detection of viable but non-culturable Pseudomonas aeruginosa in cystic fibrosis by qPCR: a validation study.
    Mangiaterra G; Amiri M; Di Cesare A; Pasquaroli S; Manso E; Cirilli N; Citterio B; Vignaroli C; Biavasco F
    BMC Infect Dis; 2018 Dec; 18(1):701. PubMed ID: 30587160
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pseudomonas aeruginosa transmission is infrequent in New Zealand cystic fibrosis clinics.
    Schmid J; Ling LJ; Leung JL; Zhang N; Kolbe J; Wesley AW; Mills GD; Brown PJ; Jones DT; Laing RT; Pattemore PK; Taylor DR; Grimwood K
    Eur Respir J; 2008 Dec; 32(6):1583-90. PubMed ID: 18715877
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Persistence of Pseudomonas aeruginosa strains in seven cystic fibrosis patients followed over 20 months.
    Godard C; Plesiat P; Michel-Briand Y
    Eur J Med; 1993 Feb; 2(2):117-20. PubMed ID: 8258014
    [No Abstract]   [Full Text] [Related]  

  • 38. Molecular analysis of changes in Pseudomonas aeruginosa load during treatment of a pulmonary exacerbation in cystic fibrosis.
    Reid DW; Latham R; Lamont IL; Camara M; Roddam LF
    J Cyst Fibros; 2013 Dec; 12(6):688-99. PubMed ID: 23706827
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome fingerprinting as a typing method used on polyagglutinable Pseudomonas aeruginosa isolates from cystic fibrosis patients.
    Ojeniyi B; Høiby N; Rosdahl VT
    APMIS; 1991 Jun; 99(6):492-8. PubMed ID: 1905144
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Pseudomonas aeruginosa and cystic fibrosis: intrastrain variability in relation to intensity of immune response and clinical outcome.
    Quentin R; Bollet C; Dayan A; Martin C; Goudeau A; De Micco P
    New Microbiol; 1993 Apr; 16(2):185-8. PubMed ID: 8510574
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.